COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 167 filers reported holding COHERUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,514 | -19.9% | 11,100 | -8.6% | 0.00% | – |
| Q2 2023 | $51,838 | -38.5% | 12,140 | -1.5% | 0.00% | – |
| Q1 2023 | $84,317 | -29.5% | 12,327 | -18.4% | 0.00% | – |
| Q4 2022 | $119,663 | -17.5% | 15,109 | -0.0% | 0.00% | – |
| Q3 2022 | $145,000 | +45.0% | 15,112 | +9.7% | 0.00% | – |
| Q2 2022 | $100,000 | -17.4% | 13,779 | +3.3% | 0.00% | – |
| Q1 2022 | $121,000 | -92.3% | 13,336 | -86.3% | 0.00% | -100.0% |
| Q3 2021 | $1,564,000 | -11.4% | 97,320 | -23.8% | 0.00% | 0.0% |
| Q2 2021 | $1,765,000 | -8.8% | 127,678 | -3.7% | 0.00% | 0.0% |
| Q1 2021 | $1,936,000 | +524.5% | 132,515 | +642.5% | 0.00% | – |
| Q4 2020 | $310,000 | +19.7% | 17,847 | +26.5% | 0.00% | – |
| Q3 2020 | $259,000 | -21.5% | 14,110 | -30.5% | 0.00% | – |
| Q1 2020 | $330,000 | +61.0% | 20,308 | +78.1% | 0.00% | – |
| Q4 2019 | $205,000 | +2.5% | 11,404 | +15.6% | 0.00% | – |
| Q3 2019 | $200,000 | – | 9,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |